Navigation Links
Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis

es in RRMS. The most common side effects of COPAXONE(R) are redness, pain, swelling, itching, a lump or an indentation at the site of injection, weakness, infection, pain, nausea, joint pain, anxiety, and muscle stiffness.

COPAXONE(R) is now approved in 47 countries worldwide, including the United States, Canada, Mexico, Australia, Israel, and all European countries. In Europe, COPAXONE(R) is marketed by Teva Pharmaceutical Industries Ltd. and sanofi-aventis. In North America, COPAXONE(R) is marketed by Teva Neuroscience, Inc., which is a subsidiary of Teva Pharmaceutical Industries Ltd (NASDAQ:TEVA). COPAXONE(R) is a registered trademark of Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the leading generic pharmaceutical company. The company develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients, as well as animal health pharmaceutical products. Close to 90 percent of Teva's sales are in North America and Europe. Teva's innovative R&D focuses on developing novel drugs for diseases of the central nervous system.

See additional important information at http://www.copaxone.com/pi/index.html or call 1-800-887-8100 for electronic releases. For hardcopy releases, please see enclosed full prescribing information.

Safe Harbor Statement under the U. S. Private Securities Litigation Reform Act of 1995: This release contains forward-looking statements, which express the current beliefs and expectations of management. Such statements are based on management's current beliefs and expectations and involve a number of known and unknown risks and uncertainties that could cause Teva's future results, performance or achievements to differ significantly from the results, performance or achievements expressed or implied by such forward-looking statements. Important factors that
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Point of Care Strep Tests Speed Treatment, Lower Costs
2. Rapid HIV Testing Increases Possibility of Treatment
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
9. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
10. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
11. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
Post Your Comments:
(Date:9/14/2014)... , September 14, 2014 ... EMITF ) announced today further to the ... 2014 (the "Company,s Previous Reports"), that it was informed ... of US$ 12.5 million by  Shanghai GEOC Hengtong Investment ... Group").In the framework of the present investment round in ...
(Date:9/12/2014)... DUBLIN, Ireland , September ... ,Research and Markets ( ... addition of the  "Global Pipeline ... Drugs (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, ... - Trends and Forecast to ...
(Date:9/12/2014)... September 12, 2014 The ... [Beverages (Alcoholic, CSD, Sports & Energy Drinks, Others), ... Meat & Seafood)], by Material (Aluminum & Steel) ... defines and segments the Food & Beverage Metal ... application in terms of volumes and values. The ...
Breaking Medicine Technology:Elbit Imaging Ltd. Announces Investment of US$ 12.5 Million in Insightec by Shanghai GEOC Hengtong Investment Limited Partnership and Fortune China Limited 2Elbit Imaging Ltd. Announces Investment of US$ 12.5 Million in Insightec by Shanghai GEOC Hengtong Investment Limited Partnership and Fortune China Limited 3Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix) - Trends and Forecast to 2020 2Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix) - Trends and Forecast to 2020 3Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 2Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 3Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 4
... International, Inc.,(Nasdaq: DATA ), a technology and services ... industry, today reported its,operating results for the first quarter ... 31, 2008, revenue decreased,approximately 41% to $2,088,000 and the ... share on both a basic and diluted basis. These,results ...
... the treatment of ... schizophrenia and bipolar I disorder, WASHINGTON, May 8 ... of asenapine clinical trials,from the Olympia program was presented at ... D.C., May 3-8. Data from,the studies, involving patients with bipolar ...
Cached Medicine Technology:DATATRAK International Reports First Quarter Results for 2008 2DATATRAK International Reports First Quarter Results for 2008 3DATATRAK International Reports First Quarter Results for 2008 4DATATRAK International Reports First Quarter Results for 2008 5DATATRAK International Reports First Quarter Results for 2008 6DATATRAK International Reports First Quarter Results for 2008 7Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 2Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 3Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 4Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 5Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 6Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 7
(Date:9/15/2014)... DC (PRWEB) September 15, 2014 ... payment initiatives that bring providers on board as ... member satisfaction. When bundled payment programs are designed ... financial incentives, incentivize hospitals to work collaboratively with ... procedure-specific tally. On Sept. 24, the Atlantic Information ...
(Date:9/15/2014)... More than 30 million additional Americans ... Care Act. This fact begs the question “are there ... reform and an aging population create a demand for ... are trying to stay on top of the anticipated ... 204 days to fill, according to the Association of ...
(Date:9/15/2014)... FL (PRWEB) September 15, 2014 (PRWEB) September 15, 2014 ... what’s not; what the startup business requirements are in ... the new business. , Speakers include industry professionals, such ... Health Center in Oakland,CA and cannabis business consultant ... , who are already successfully running legal marijuana businesses ...
(Date:9/14/2014)... Petersburg, FL (PRWEB) September 15, 2014 Skin ... external factors like sun damage and not moisturizing properly. However, ... if skin has been cared for. , Two main reasons ... 2) Loss of hyaluronic acid in the skin , During ... and both of these are responsible for important moisture retention ...
(Date:9/14/2014)... (PRWEB) September 14, 2014 Government ... growth of the patient handling equipment market , ... lucrative growth potential for the next five years. ... the rise in geriatric population and increasing lifestyle ... leading to increased disabilities. Further the market is ...
Breaking Medicine News(10 mins):Health News:Sept. 24 Webinar to Profile Geisinger Health System, BCBS of North Carolina’s Successful Bundled-Payment Programs 2Health News:Affordable Care Act Poses Challenge for Hospital Recruiters, with Nationwide Physician Shortage Looming in the Near Future 2Health News:How to Start And Run a Successful Legal Marijuana Business 2Health News:2 Reasons Skin Becomes Dryer with Age and What To Do About It, From Sublime Beauty® 2Health News:2 Reasons Skin Becomes Dryer with Age and What To Do About It, From Sublime Beauty® 3Health News:10.7% CAGR For Patient Handling Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 2Health News:10.7% CAGR For Patient Handling Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 3Health News:10.7% CAGR For Patient Handling Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 4
... , ... (Vocus) December 8, 2008 -- Losing a child to the ... , it is a tragedy they have experienced firsthand. The nonprofit organization ... the flu or have had a child experience severe medical complications from ...
... 8 - 14; Urges Immunization into December, January and Beyond ... Dec. 8 Mothers -- often the family,s primary healthcare ... families vaccinated against influenza throughout the winter months and even ... American Lung Association as part of its Faces of ...
... suggests it,s a promising candidate as marker for metastasis ... that may contribute to the spread of breast cancer ... (called Menainv) is present in invasive cells within a ... biomarker for metastatic breast cancer, the scientists said. , ...
... Technologies(R), a leading,provider of radio frequency identification systems and ... Designed to allow,hospitals easier access to the Safe Place ... financing, this option is especially helpful,in today,s tight economy. ... to offer a new way for hospitals to implement ...
... Conn., Dec. 8 SearchMedica.com,( http://www.searchmedica.com/ ), the ... new Radiology search channel. The search,channel connects radiologists ... relevant online medical imaging resources. , ... medical professional at some point,no matter what their ...
... to keep,families healthy and make it easier to get a ... largest retail health,care clinic in the U.S., announced that they ... this Fall,s flu shot season. , ... (NYSE: CVS ), launched,an integrated campaign on Oct. ...
Cached Medicine News:Health News:For Kids, the Flu Can Be Severe, Even Deadly 2Health News:For Kids, the Flu Can Be Severe, Even Deadly 3Health News:Survey Shows Mothers See Value in Influenza Vaccination for Their Families Through the Winter and Spring 2Health News:Survey Shows Mothers See Value in Influenza Vaccination for Their Families Through the Winter and Spring 3Health News:Survey Shows Mothers See Value in Influenza Vaccination for Their Families Through the Winter and Spring 4Health News:Survey Shows Mothers See Value in Influenza Vaccination for Their Families Through the Winter and Spring 5Health News:Scientists ID Protein Aiding Breast Cancer Spread 2Health News:RF Technologies(R) Introduces Safe Place(R) Usage Program Financing for Its Infant Security, Pediatric Security and ED Safety Solutions 2Health News:RF Technologies(R) Introduces Safe Place(R) Usage Program Financing for Its Infant Security, Pediatric Security and ED Safety Solutions 3Health News:SearchMedica Launches Radiology Search Channel for Medical Professionals 2Health News:CVS/pharmacy and MinuteClinic Reach Goal of Delivering One Million Flu Vaccinations 2Health News:CVS/pharmacy and MinuteClinic Reach Goal of Delivering One Million Flu Vaccinations 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: